Upstart Cell Biosciences Acquires Protein Forest as it Continues on Growth Curve | GenomeWeb

This story originally ran on Dec. 7.

By Tony Fong

Nano-proteomics technology development firm Cell Biosciences today announced that it has acquired sample preparation firm Protein Forest for an undisclosed price in a deal designed to accelerate its growth in the proteomics space.

In connection with the all-stock transaction, Cell Biosciences said it raised an additional $4 million in equity financing. Novo A/S, an existing investor in the firm, led the financing round.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.